Erythropoietin-producing hepatocellular receptor A7 restrains estrogen negative feedback of luteinizing hormone via ephrin A5 in the hypothalamus of female rats

Am J Physiol Endocrinol Metab. 2020 Jul 1;319(1):E81-E90. doi: 10.1152/ajpendo.00046.2020. Epub 2020 May 12.

Abstract

We have previously shown that systemic injection of erythropoietin-producing hepatocellular receptor A7 (EPHA7)-Fc raises serum luteinizing hormone (LH) levels before ovulation in female rats, indicating the induction of EPHA7 in ovulation. In this study, we aimed to identify the mechanism and hypothalamus-pituitary-ovary (HPO) axis level underlying the promotion of LH secretion by EPHA7. Using an ovariectomized (OVX) rat model, in conjunction with low-dose 17β-estradiol (E2) treatment, we investigated the association between EPHA7-ephrin (EFN)A5 signaling and E2 negative feedback. Various rat models (OVX, E2-treated OVX, and abarelix treated) were injected with the recombinant EPHA7-Fc protein through the caudal vein to investigate the molecular mechanism underlying the promotion of LH secretion by EPHA7. Efna5 was observed strongly expressed in the arcuate nucleus of the female rat by using RNAscope in situ hybridization. Our results indicated that E2, combined with estrogen receptor (ER)α, but not ERβ, inhibited Efna5 and gonadotropin-releasing hormone 1 (Gnrh1) expressions in the hypothalamus. In addition, the systemic administration of EPHA7-Fc restrained the inhibition of Efna5 and Gnrh1 by E2, resulting in increased Efna5 and Gnrh1 expressions in the hypothalamus as well as increased serum LH levels. Collectively, our findings demonstrated the involvement of EPHA7-EFNA5 signaling in the regulation of LH and the E2 negative feedback pathway in the hypothalamus, highlighting the functional role of EPHA7 in female reproduction.

Keywords: EFNA5; EPHA7; estradiol; estrogen receptor-α; hypothalamus; luteinizing hormone.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arcuate Nucleus of Hypothalamus / drug effects
  • Arcuate Nucleus of Hypothalamus / metabolism
  • Ephrin-A5 / drug effects
  • Ephrin-A5 / genetics
  • Ephrin-A5 / metabolism*
  • Estradiol / pharmacology
  • Estrogen Receptor alpha / metabolism*
  • Estrogen Receptor beta / metabolism
  • Estrogens / pharmacology
  • Feedback, Physiological / drug effects
  • Feedback, Physiological / physiology
  • Female
  • Gonadotropin-Releasing Hormone / drug effects
  • Gonadotropin-Releasing Hormone / metabolism*
  • Hormone Antagonists / pharmacology
  • Hypothalamo-Hypophyseal System / drug effects
  • Hypothalamo-Hypophyseal System / metabolism
  • Hypothalamus / drug effects
  • Hypothalamus / metabolism*
  • Luteinizing Hormone / drug effects
  • Luteinizing Hormone / metabolism*
  • Oligopeptides / pharmacology
  • Ovariectomy
  • Ovary / drug effects
  • Ovary / metabolism
  • Protein Precursors / drug effects
  • Protein Precursors / metabolism*
  • Rats
  • Receptor, EphA7 / genetics
  • Receptor, EphA7 / metabolism
  • Receptor, EphA7 / pharmacology
  • Recombinant Proteins

Substances

  • Ephrin-A5
  • Estrogen Receptor alpha
  • Estrogen Receptor beta
  • Estrogens
  • Hormone Antagonists
  • Oligopeptides
  • Protein Precursors
  • Recombinant Proteins
  • progonadoliberin I
  • Gonadotropin-Releasing Hormone
  • Estradiol
  • Luteinizing Hormone
  • Receptor, EphA7
  • abarelix